Background. We endeavored to construct a simple score based entirely on epidemiological and clinical variables that would stratify patients who require hospital admission because of community-acquired pneumonia into groups with a low or high risk of developing bacteremia.
with infectious diseases. Unfortunately, with currently available diagnostic techniques this information is not available for many patients with community-acquired pneumonia (CAP). Most subjects do not produce a sputum sample of good quality for Gram staining, and the results obtained for sputum culture lack specificity. Additionally, samples of pleural fluid usually cannot be obtained, and the usefulness of urine antigen-detection tests and serum serological methods is restricted to the identification of specific agents, leaving out the most aggressive and drug-resistant pathogens [1] .
In this context, blood cultures could be an important tool in the search for the etiology of CAP; in fact, they have become one of the most used diagnostic methods [1] [2] [3] . Blood culture is a polyvalent diagnostic test that is simple to obtain and relatively inexpensive. Moreover, the specificity of the test is high if skin contaminants are excluded, and it allows for the recognition of antimicrobial resistance. However, the yield of the procedure is low, with sensitivity levels of ∼10%-15%. Consequently, many investigators have questioned the cost-effectiveness of the technique [4, 5] .
Previous reports have suggested that the risk of bacteremia can be influenced by some clinical factors. As expected, it has been recognized that prior antibiotic therapy reduces the sensitivity of culture [1] . There is also evidence suggesting a relationship between bacteremia and some epidemiological or clinical factors, such as immunosuppression, septic shock, and a severe clinical course [6, 7] . Finally, a previous retrospective study demonstrated an association between bacteremia and liver disease, 3 vital signs, and 3 laboratory abnormalities [8] .
The purpose of the present study was to construct and validate a scoring method based on simple epidemiological and clinical data available at the bedside for estimating the risk of bacteremia in an unselected population of immunocompetent adult patients with CAP.
METHODS

Derivation and Internal Validation Step
Selection of patients. Patients included in this study were identified from a common database available at 2 acute-care university hospitals in Catalonia, Spain-the Hospital de Bellvitge in Barcelona and the Hospital Arnau de Vilanova in Lleida. The study was approved by the scientific and ethics committees of these institutions.
At both centers, data on all consecutive immunocompetent patients who were у18 years old and hospitalized with CAP were prospectively collected over a 10-year period (January 1996 through December 2005). CAP was defined as an acute illness with features of a lower respiratory tract infection, the presence of an infiltrate on the chest radiograph consistent with acute infection, and 2 or more of the following clinical parameters: fever, chills, cough, sputum production, pleuritic pain, and signs of lung consolidation.
Exclusion criteria were tuberculosis or infection caused by fungi or opportunistic microorganisms; immunosuppression, including that caused by human immunodeficiency virus infection, hematologic neoplasms, solid-organ and bone-marrow transplantation, neutropenia, and treatment with immunosuppressive drugs or corticosteroids at a daily dose of у20 mg of prednisolone or the equivalent; absence of blood cultures performed before the start of treatment in the hospital; and nosocomial or health care-associated acquisition of pneumonia.
Data collection. A unified protocol was established for the collection of data and the definition of the variables. The database contained 180 parameters related to the baseline characteristics of patients, microbiological results, therapeutic regimens, and outcomes. However, to derive and validate the present clinical rule we used only epidemiological and clinical parameters at entry. The results of the blood analysis were used to categorize the severity of illness at admission, according to the pneumonia severity index (PSI) [9] . The following variables were evaluated as potential predictive factors: epidemiologic data (age, sex, smoking habit, alcohol abuse, prior antibiotic therapy, chronic obstructive pulmonary disease, diabetes mellitus, chronic heart failure, neoplasm, chronic renal insufficiency, chronic liver disease, and cerebrovascular disease with significant sequelae); clinical findings (acute onset of disease, duration of clinical picture, chills, cough, expectoration, pleuritic pain, signs of pulmonary consolidation, and acute mental confusion); vital signs measured at the time of blood collection (body temperature, respiratory rate, heart rate, arterial systolic and diastolic blood pressure, and oxygen saturation measured by pulse oximetry with the patient not receiving supplemental oxygen); radiological features (pleural effusion and extent of pulmonary infiltrate [lobar vs multilobar]); and PSI.
Blood collection and culture. Blood was obtained and cultured using routine techniques. Briefly, after the diagnosis of CAP was established and before treatment, 10 mL of blood was obtained and inoculated into 2 culture bottles (5 mL was inoculated into an aerobic bottle and 5 mL into an anaerobic bottle). Thirty minutes later, an additional 10 mL of blood was obtained from a different site, and the procedure was repeated. Blood culture bottles were conventionally processed in an automated blood culture system. The following isolates were always considered to be contaminants: coagulase-negative staphylococci, Micrococcus species, Propionibacterium species, and diphteroids.
Score derivation. Data were analyzed using a commercially available software package (SPSS for Windows, version 12.0; SPSS). Patients were randomized into 2 groups to create a derivation cohort with the 60% of the samples and an internal validation cohort with the remaining 40%. We evaluated all the selected epidemiological and clinical variables by performing univariate analysis to determine the significance and strength of the association between each candidate predictor and bacteremia. We assessed significance by the x 2 or Fisher exact test for categorical variables and the Student t test for continuous variables. Two-tailed was considered to indicate statis-P ! .05 tical significance.
Multivariate analysis was performed to determine factors that were independently associated with bacteremia. For these analyses, we selected all potential predictive factors, including all variables found to be significant in the univariate analysis, and entered them into a final model using stepwise multiple logistic regression analysis. To simplify the application of the rule, con-tinuous variables were recategorized into binary factors using the most discriminant cutoff point. Results of multivariate analysis are reported as odds ratios with 95% confidence intervals (CIs) and P values.
The logistic regression model coefficients for statistically significant predictors of bacteremia were used to assign the value (risk score) of each variable. We then computed the score for each patient reflecting the probability of bacteremia and chose the cutoff value that discriminated between the low and the high probability groups. Finally, we performed a receiveroperating characteristic (ROC) curve analysis and computed the area under the ROC curve (AUC) and its corresponding 95% CI.
Internal validation. We applied the resultant prediction score to the cohort including the 40% of patients reserved for the internal validation, and rates of bacteremia for each prediction level were calculated. We also performed ROC curve analysis in this population.
External Validation Step
We validated the score in an independent cohort of patients included in a prospective study promoted by the Group of Respiratory Infections from the Sociedad Española de Patología del Aparato Respiratorio. A total of 13 Spanish general hospitals entered into the study, which included all consecutive patients admitted to the hospital for CAP in a 12-month period (January through December 2007). The study was approved by the scientific and ethics committees of participating institutions. Definitions of CAP and variables, inclusion and exclusion criteria, and methods for blood cultures were similar to those used for the derivation and internal validation groups.
Similar to the internal validation, we assessed the predictive accuracy of the score in the external validation cohort by calculating the prevalence of bacteremia in the clinical probability categories according to the point assignment. We also assessed the discrimination ability of the score by means of an ROC curve analysis.
RESULTS
Derivation and Internal Validation
Study population. A total of 3116 patients with recorded cases satisfied the inclusion and exclusion criteria and were enrolled in the retrospective study for derivation and internal validation. Patients with missing values were excluded from the analysis, and the remaining 2286 patients were analyzed for the study.
True pathogens were detected in 322 episodes (15%), and contaminants were detected in 148 (6%). Among the true pathogens, Streptococcus pneumoniae was the most frequently isolated bacterium, found in 277 (82%) patients. This was followed by Haemophilus influenzae, found in 14 (4%); viridans streptococci, found in 11 (3%); Staphylococcus aureus, found in 6 (2%); Pseudomonas aeruginosa, found in 5 (2%); Escherichia coli, found in 5 (2%); and Klebsiella pneumoniae, found in 4 (1%). Other pathogens were found in 13 (4%). Polymicrobial infections were detected in 3 patients.
Of these 2286 patients, 1386 (60%) were randomly assigned to the derivation cohort, and 900 (40%) were assigned to the internal validation cohort. The baseline characteristics and microbiological findings for both cohorts of patients are shown in tables 1 and 2.
Score derivation. The univariate analysis identified 14 variables that were significantly associated with bacteremia, including epidemiological factors (chronic liver disease and absence of prior antibiotic use), clinical findings (acute onset of disease, length of disease, chills, cough, expectoration, and pleuritic pain), vital signs (heart rate, respiratory rate, systolic blood pressure, and oxygen saturation), and radiological features (pleural effusion and multilobular infiltration) (table 3). The distribution of patients in the PSI categories was also related to bacteremia, with the risk increasing progressively (8%, 9%, 12%, 15%, and 29% for classes 1-5, respectively).
To perform the multivariate analysis, continuous variables were categorized into binary factors using the following threshold values: age 165 years, length of illness !72 h, temperature !35ЊC or 140ЊC, heart rate 1125 beats/min, respiratory rate 130 cycles/min, systolic blood pressure !90 mm Hg, diastolic blood pressure !60 mm Hg, and oxygen saturation !92%. In the multivariate analysis, only 6 of these potential predictive factors remained significantly associated with bacteremia: absence of prior antibiotic therapy, chronic liver disease, pleuritic pain, tachycardia, tachypnea, and systolic hypotension (table 4).
Results from the multivariate analysis were used to develop the clinical prediction rule. According to the regression coefficients, we assigned 1 point to each independent parameter. The application of the score to patients enabled us to categorize subjects into 5 different classes on the basis of the predicted probability of bacteremia: 122 (9%) had 0 points, 482 (35%) had 1 point, 496 (36%) had 2 points, 244 (18%) had 3 points, and 42 (3%) had 4 or more points (only 2 patients had 14 points). The incidence of bacteremia in these groups was 3%, 8%, 15%, 24%, and 38%, respectively (table 5). When measured by the AUC, the prediction rule showed an accuracy of 0.70 (95% CI, 0.66-0.74). For patients admitted to the intensive care unit, bacteremia rates were 0% (0 of 6), 12% (3 of 25), 37% (19 of 51), 58% (7 of 12), and 50% (1 of 2), respectively, showing an AUC of 0.67 (95% CI, 0.59-0.76).
Internal validation. The score predicted the incidence of bacteremia well when it was applied to the internal validation cohort across all risk classes. For patients included in the internal validation group, we obtained incidences of bacteremia that began at 3% for patients who had no risk factors and that Chronic heart failure 280 (20) 184 (20) 154 (14) Chronic liver disease 69 (5) 35 (4) 54 (5) Chronic renal disease 50 (4) 35 (4) 63 (6) Neoplasm 98 (7) 67 (8) progressively increased to 63% for patients with 4 or more risk factors (table 5) . This is an accuracy of 0.69 (95% CI, 0.65-0.74), as measured by the AUC.
External Validation
A total of 1369 patients who were admitted to 13 Spanish hospitals and were prospectively enrolled in the study formed the external validation cohort. However, 242 were excluded because they had variables with missing values; thus, 1127 patients were analyzed. Table 1 shows the baseline demographic and clinical characteristics of these patients, and table 2 shows microbiological results of blood cultures.
The incidences of bacteremia ranged from 3% for patients without risk factors to 29% for subjects with 4 or more risk factors (table 5) , with an AUC of 0.67 (95% CI, 0.62-0.71). A comparison of the results obtained with the application of the score to the different cohorts of patients and categories of risk is shown in table 5. In the 3 cohorts, between 43% and 49% of patients were categorized as having 1 or 0 points, with a corresponding bacteremia rate !8%.
DISCUSSION
In the present study, a very simple score was generated that estimates the risk of bacteremia in patients with CAP, and the model was internally and externally validated. The presence of chronic liver disease, pleuritic pain, tachycardia, tachypnea, and systolic hypotension and the absence of prior antibiotic therapy were identified through multivariate analysis as predictors of bacteremia. The coincidence of 2 or more of these predictive factors carried a substantial risk of bacteremia, thereby justifying culture of blood from patients with these risk factors.
To predict bacteremia in patients with CAP, prior experiences have been reported without fully resolving the issue [8, 10, 11] . The most substantive study was published by Metersky et al [8] in 2004. They developed a prediction tool using the following variables as predictors: recent antibiotic treatment, liver disease, 3 vital signs (systolic blood pressure !90 mm Hg, temperature !35ЊC or у40ЊC, and pulse у125 beats/min), and 3 laboratory measurements (blood urea nitrogen level у30 mg/ dL, sodium level !130 mmol/L, and white blood cell count !5000 or 120000 cells/mm 3 ). Patients were categorized into 3 groups with a low (2%), moderate (5%), and high (11%) risk of bacteremia. However, the authors recognized that the study had some limitations. Specifically, data were retrospectively collected from Medicare patients (only 10% of patients were !65 years old), and subjects had been discharged with a diagnosis of pneumonia, septicemia, or respiratory failure. In addition, the spectrum of isolated bacteria was not concordant with the expected flora, showing a relatively low incidence of S. pneumoniae and a high frequency of relatively uncommon agents, such as S. aureus and gram-negative bacilli [12] . Furthermore, this model was not prospectively validated.
Because of this poor scientific evidence, the current guidelines are imprecise and recommend that blood cultures be performed for all patients with severe CAP; the culture of blood from the remaining subjects requiring hospital admission is optional [13] . Undoubtedly, severity of illness, usually estimated using the PSI or CURB-65 prognostic rules, cannot be used as the exclusive criterion for selecting patients at risk for bacteremia. In these rules, parameters such as age and, in the PSI, some underlying diseases (conditions unrelated to bacteremia, as specific studies have found) play a very important role [14, 15] . Previous reports had already demonstrated a weak correlation between the PSI classification and bacteremia [5, 6] , and our results are consistent with this observation. Thus, 45% of patients with bacteremia in our study were classified in lowseverity categories (PSI class I, II, or III).
Several aspects of the immune system-including the activity of the reticuloendothelial system, polymorphonuclear leukocyte function (eg, leukocyte adherence, chemotaxis, and phagocytosis), and bactericidal activity of serum-are depressed in patients with chronic liver diseases, who have a high predisposition to bacterial infections [16] . Thus, chronic liver diseases have been identified as risk factors for bacteremia in patients with sepsis [17] . Similarly, many epidemiological studies have demonstrated that prior use of antibiotics reduces the rate of positive results from diagnostic tests based on the isolation of microorganisms from culture [1, [18] [19] [20] . In the study by Metersky et al [8] , both chronic liver disease and the lack of prior antibiotic therapy were also associated with bacteremia.
On the other hand, a greater presence of clinical symptoms and signs of pneumonia-particularly pleuritic pain-has been traditionally related to the bacterial etiology, not to atypical agents [21, 22] . In the present study, most of these clinical manifestations were associated with bacteremia in the univariate analysis, and pleuritic pain was identified as an independent factor in the multivariate analysis. Pleuritic pain probably summarizes features that define the typical clinical picture that is more frequently caused by pathogens that can be recovered from the blood. The remaining parameters selected in this model are 3 vital signs that are related to a more severe clinical presentation.
In patients with severe CAP, antibiotic treatment should be initiated promptly after the diagnosis of pneumonia is established on the basis of a chest radiograph [13, 23] . Similarly, specimens for culture should be obtained before the start of treatment in order to increase the likelihood of detecting bac- teremia [19] . Therefore, the collection of blood for culture needs to be done early, usually when laboratory data are still not available. Even more, it would be advisable to simultaneously collect blood for laboratory analyses and culture. To apply our scoring system, only 6 epidemiological and clinical variables need to be known, and they are available at presentation for almost all patients, are very easy to obtain, and are not subject to the ability of the physician. Our predictive model clearly discriminates between 2 situations. A subgroup of patients have a low risk of bacteremia (score, р1), with a rate of positive blood culture results !8%. In these low-risk cases, many clinicians can rightfully consider this diagnostic method unjustified. Conversely, the bacteremia rate can reach between 14% and 63% for the remaining patients (score, у2). For these patients, blood cultures can be considered useful diagnostic methods. If this prediction rule is applied, the number of tests performed for patients with pneumonia will be substantially reduced. Although this practice may not detect ∼10% of cases, it is more desirable than the elimination of blood cultures from the diagnostic approach to CAP, as some authors have reasonably suggested [24] .
The accuracy of our method is good but not excellent, as the statistical analysis demonstrates (AUC, 0.70). We can find positive blood culture results for patients who had no risk factors. In such patients, an underlying immunodeficiencyparticularly human immunodeficiency virus infection-must be excluded [7] . Additionally, even among patients with many predictive factors, only 1 positive result will be obtained for every 2 or 3 patients evaluated.
In summary, the risk of bacteremia in CAP can be estimated by evaluating simple epidemiological and clinical factors. Our prediction model allows for the stratification of patients according to the risk of bacteremia. This identifies a subgroup of low-risk patients for whom blood cultures would have little diagnostic value. Conversely, blood collection for culture appears to be fully justified for the remaining subjects.
NAC-CALIDAD (PROYECTO INTEGRADO DE INVESTIGACIÓ N DE LA SOCIEDAD ESPAÑ OLA DE PATOLOGÍA DEL APARATO RESPIRATORIO SOBRE INFECCIONES RESPIRATORIAS DE VÍAS BAJAS) STUDY GROUP MEMBERS
